Fair Accountability and Innovative Research Drug Pricing Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Mar 23, 2021)
Fair Accountability and Innovative Research Drug Pricing Act of 2021
This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.
What just happenedMar 23, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
- Introduced in SenateMar 23, 2021
- Mar 23, 2021IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health, Education, Labor, and Pensions Committee - Mar 23, 2021IntroReferral10000
Introduced in Senate